AI in Pharma

December 4-5, 2018

Investment and the application of AI in the pharmaceutical industry is rapidly gaining momentum. We bring together CEOs, CIOs, CTOs and Global AI, IT and Informatics Experts from leading pharmaceutical and technology companies to give strategic and visionary talks based on use cases throughout the drug development pipeline.

If you would like to submit a proposal to give a presentation at this meeting, please click here.

OPENING KEYNOTE PRESENTATIONS

The Potential for Advanced Analytics in the Pharmaceutical Industry
Michael Ringel, PhD, Senior Partner and Managing Director, Boston Consulting Group (BCG)

Why Is the Pharmaceutical Industry Finding AI so Difficult?
Peter Henstock, AI & Machine Learning Lead, Pfizer

Implementing Digital and AI Strategies across Organizations within Sanofi
Natalija Jovanovic, Head Digital Catalyst, Sanofi

DISRUPTING DRUG DISCOVERY: TARGET IDENTIFICATION, CHEMISTRY AND SCREENING

Integrating AI Workflows in Drug Discovery
John Baldoni, Senior Vice President, In silico Drug Discovery, GlaxoSmithKline

The Big Data Revolution: Can AI Shape Drug Discovery?
Litao Zhang, PhD, Vice President, Leads Discovery & Optimization, Disease Sciences & Biologics, BMS

INTERACTIVE PANEL DISCUSSION: The Use of AI to Disrupt Drug Discovery: How to Reduce Time and Costs and Increase Throughput

Moderator: Alex Zhavoronkov, Founder, Insilico Medicine
Panelists:Mark Davies, Vice President Biomedical Informatics, Benevolent AI

Eric Neumann, CEO & Founder, Aidaka

Ed Addison, CEO, Cloud Pharmaceuticals

PRACTICAL IMPLEMENTATION OF AI IN THE TRANSLATIONAL AND CLINICAL ENVIRONMENTS

Session Chairperson: Dany De Grave, Senior Director, Innovation Programs and External Networks, Sanofi

Data Store: Making All Data Machine Learnable at NIBR
John R. Walker, Head of Core Data and Analytics, NIBR Informatics, Novartis

Defining the Strategy and Application of AI in Clinical Trials and Real-World Evidence
Carolyn Cho, Director, Immunology Therapeutic Area Pharmacometrics Lead, Merck

INTERACTIVE PANEL DISCUSSION: Can AI & ML Make Clinical Trials Faster, More Effective and Patient Centric?

Moderator: Craig Lipset, Head of Clinical Innovation, Pfizer
Panelists: Ted Slater, Global Head, Scientific AI & Analytics, Cray

Balazs Flink, MD, Clinical Trial Analytics Lead, R&D Business Insights and Analytics, Bristol-Myers Squibb

Sara Holoubek, CEO, Luminary Labs

REDEFINING THE REGULATORY LANDSCAPE

Exploring New Ways of Working in Regulatory: Sanofi’s Proof of Concept Pilot
Dany De Grave, Senior Director, Innovation Programs and External Networks, Sanofi